Page 111 - E-book การประชุมวิชาการครั้งที่ 36
P. 111
fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein
and unconjugated oestriol. Hum Reprod 1998;13:220-3.
12. Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S,
Traisrisilp K, Jatavan P, Tongsong T. Fetal Down syndrome screening models for developing
countries; Part I: Performance of Maternal Serum Screening. BMC Health Serv Res. 2019 Nov 27;19:
897.
13. Wanapirak C, Buddhawongsa P, Himakalasa W, Sarnwong A, Tongsong T. Fetal Down
syndrome screening models for developing countries; Part II: Cost-benefit analysis. BMC Health
Serv Res. 2019;19:898.
14. DeVore GR. The role of fetal echocardiography in genetic sonography. Semin Perinatol
2003 Apr;27:160-72.
15. DeVore GR. Trisomy 21: 91% detection rate using second-trimester ultrasound markers.
Ultrasound Obstet Gynecol 2000 Aug;16:133-41.
16. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet
Gynecol 2007 Jan;109:217-27.
Down Syndrome Screening: From Theory to Practical and Policy 95
